TriSalus Life Sciences Inc. (TLSI)
NASDAQ · Healthcare
TriSalus Life Sciences Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 45.2M | 29.4M | 18.5M | 12.4M |
| Gross Profit | 38.2M | 25.3M | 15.9M | 10.1M |
| Profitability | ||||
| Operating Income | -26.9M | -36.2M | -54.5M | -36.4M |
| EBITDA | -26.3M | -35.4M | -53.8M | -36.0M |
| Net Income | -39.2M | -30.0M | -59.4M | -47.2M |
| Per Share Data | ||||
| EPS (diluted) | $-1.84 | $-1.31 | $-6.77 | $-161.55 |
| Shares Outstanding (dil.) | 38M | 25M | 9M | 0M |
TriSalus Life Sciences Inc. Income Statement — FAQ
TriSalus Life Sciences Inc. (TLSI) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TLSI's income statement history?
The chart and table above show TriSalus Life Sciences Inc.'s income statement by year and by quarter, including the growth rate.